9.63
+0.08(+0.84%)
Currency In USD
Address
201 Haskins Way
South San Francisco, CA 94080
United States of America
Phone
650-407-2376
Website
Sector
Healthcare
Industry
Biotechnology
Employees
8
First IPO Date
November 30, 2021
| Name | Title | Pay | Year Born |
| Mr. Christopher B. Ehrlich M.B.A. | Chief Executive Officer & Chair | 1.08M | 1970 |
| Mr. Andrew Albert Kucharchuk M.B.A. | Chief Financial Officer | 252,000 | 1981 |
| Dr. Kristen Pierce Ph.D. | Chief Development Officer | 360,000 | 1971 |
| Dr. Lawrence Corey M.D. | Co-founder & Head of Scientific Advisory Board | 0 | 1947 |
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.